# Treatment of Digital Ulcers in Korean Patients With Systemic Sclerosis: a Prospective Cohort Study

> **NCT02642146** · — · TERMINATED · sponsor: **Seoul National University Hospital** · enrollment: 71 (actual)

## Conditions studied

- Raynaud Disease
- Systemic Sclerosis
- Digital Ulcer

## Interventions

- **DRUG:** Calcium Channel Blockers
- **DRUG:** Phosphodiesterase Inhibitors
- **DRUG:** Endothelin receptor blocker
- **DRUG:** Prostanoids
- **DRUG:** Other vasodilator

## Key facts

- **NCT ID:** NCT02642146
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2015-01
- **Primary completion:** 2019-06
- **Final completion:** 2019-06
- **Target enrollment:** 71 (ACTUAL)
- **Why stopped:** We decided to terminate recruit earlier because patient recruiting was not active as expected at the beginning of the study.
- **Last updated:** 2020-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02642146

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02642146, "Treatment of Digital Ulcers in Korean Patients With Systemic Sclerosis: a Prospective Cohort Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02642146. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*